UK materials technology co CSMA sets sights on US:
This article was originally published in Clinica
Executive Summary
UK materials analysis specialist CSMA has announced plans to expand into North America, initially by setting up a surface characterisation service in the US, by the end of 2005. CSMA's plans are bolstered by the addition of a new time-of-flight secondary ion mass spectrometer, in which it has invested £500,000 ($934,000). Cardiovascular stents and orthopaedic implants are among the technologies that the company has helped to develop through its surface characterisation services to manufacturers. The technology has also been used to detect proteins on surgical instruments. CSMA and its parent company CERAM (British Ceramic Research) are based in Penkhull, Stoke-on-Trent (Staffordshire).